See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.27▲ 3.82%
← PXM page
XStocksXray
Market X-Ray report · 23 October 2026

Polimex-Mostostal S.A. (PXM)

Warsaw Stock Exchange · Poland · prices in PLN · close of 23 Oct 2026

Key indicators

Last closePLN 7.520
52-week range5.510 – 9.970
Return, 1 month / 3 months+8.7% / +10.6%
Return, 1 year / 3 years+17.3% / +79.0%
TrendBelow its 200-day average
RSI (14)55
Volatility (1 year)49.6%
Worst drawdown (1 year)-36.0%
Average daily value traded4.82M PLN
Dividend yield–

Market X-Ray price-based

54/ 100 · High confidence · ahead of 55% of stocks on this exchange
Trend43
Momentum55
Stability (higher is calmer)41
Liquidity94
Income–

Five-year price chart navy: price · brown: 200-day average

1.333.545.767.9710.182021-102023-012024-042025-072026-10

About the company

Polimex-Mostostal is a Polish engineering and construction group based in Warsaw. It carries out building and industrial projects, including power and energy facilities, chemical and industrial plants, and steel structures and machinery. Its customers are mainly industrial firms, utilities and public institutions in Poland and abroad. The company also provides general contracting and engineering services for large technical projects.

The shares are listed on the Warsaw Stock Exchange in Poland under the code PXM, and the price on this page is in Polish zloty (PLN). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Polimex-Mostostal S.A. (PXM) trades on the Warsaw Stock Exchange in Poland. It last closed at PLN 7.520 on 23 October 2026.

Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 264 of 580 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 17.3% and over the last three months it rose 10.6%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Polimex-Mostostal S.A. (PXM)

The five lenses in numbers each metric is ranked against the other stocks on Warsaw Stock Exchange

Lens and metricValueScoreReading
Trend43 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-3.8%
From 52-week high-22.6%
Momentum55 · FairTypical recent returns for this exchange.
3-month return10.6%
6-month return-17.3%
12-month return, skipping the last month8.0%
Stability (higher is calmer)41 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)49.6%
Worst drawdown, 1 year (smaller is calmer)-36.0%
Liquidity94 · StrongTrades actively.
Average daily value traded4.82M PLN
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−0.9%
1 month+8.7%
3 months+10.6%
6 months−17.3%
1 year+17.3%
3 years+79.0%
5 years+70.1%

Signals

50-day / 200-day average7.316 / 7.819
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.246

Technical summary

DailyStrongly bullish11 bullish · 4 neutral · 1 bearish
WeeklyStrongly bullish9 bullish · 1 neutral · 2 bearish
MonthlyStrongly bullish6 bullish · 1 neutral · 1 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Warsaw Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 24 Oct 2026